Sanofi India Limited has submitted the Exchange a copy of the Scrutinizer's report for the Postal Ballot to seek the Members' approval for the appointment of Mr. Rachid Ayari (DIN: 10408699) as the Interim Managing Director of the Company and Mr. Mahadev Gawade (DIN: 11231316) as a Director & Whole-time Director of the Company.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sanofi India has filed the Scrutinizer's report for a Postal Ballot conducted to seek shareholders' approval for two key board appointments. Mr. Rachid Ayari (DIN: 10408699) is proposed to be appointed as the Interim Managing Director, and Mr. Mahadev Gawade (DIN: 11231316) as a Director and Whole-time Director of the company. The filing confirms that the voting process for these appointments has been completed and the report has been submitted to the exchanges for member approval.
These appointments fill critical leadership roles at Sanofi India. The 'interim' nature of the MD appointment suggests a temporary arrangement, which shareholders and investors should watch for any transition to a permanent Managing Director in the near term.